CV Risk guidelines for Indonesia: What and how to follow?
Lecture held by prof Renan Sukmawan, MD, Harapan Kita National Cardiovascular Centre, Jakarta-Indonesia, during the CV Risk Master Class held on October 22, 2016 in Yogyakarta, Indonesia
The overall educational objectives of the Cardiovascular Master Class were:
- To review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk in Indonesia
- To review new data on the pathophysiology of coronary artery disease and stroke and its relevance to treatment strategies and outcomes
- To understand the medical need for intensive lipid and hypertension management in patients at high CV risk, such as DM and metabolic syndrome.
- To understand the pharmacologic and clinical rationale for various treatment options in the patients with increased CV risk and integrate scientific evidence from key clinical trials into clinical practice
- Develop a consensus on practical guidelines for day-to-day management of high risk patients
This Master Class was endorsed and accredited by the Indonesian Cardiology Association
Renan Sukmawan, MD is Consultant Cardiologist and Head of Research Institute at the Harapan Kita National Cardiovascular Center, Jakarta, and Lecturer at the Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Jakarta.
The CV Risk Master Class was funded by an unrestricted educaional grant provided by Pfizer